A 30-Month Analysis Demonstrates the Long-Term Efficacy and Safety of Sonidegib for Locally Advanced or Metastatic Basal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Only registered members have full access to PracticeUpdate content.